Total Payments
$756.92
2023 Payments
$71.86
Companies
17
Transactions
44
Medicare Patients
3,922
Medicare Billing
$364,879
Payment Breakdown by Category
Food & Beverage$756.92 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $756.92 | 44 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $124.60 | 8 | $0 (2022) |
| Novo Nordisk Inc | $110.59 | 6 | $0 (2022) |
| Daiichi Sankyo Inc. | $74.42 | 4 | $0 (2021) |
| PFIZER INC. | $66.30 | 5 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $53.02 | 3 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $49.12 | 3 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $45.01 | 3 | $0 (2021) |
| ABBVIE INC. | $42.22 | 2 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $34.61 | 2 | $0 (2022) |
| Lilly USA, LLC | $31.63 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $71.86 | 3 | Lilly USA, LLC ($31.63) |
| 2022 | $194.36 | 11 | Novo Nordisk Inc ($74.43) |
| 2021 | $248.96 | 15 | GlaxoSmithKline, LLC. ($80.00) |
| 2020 | $121.28 | 7 | AstraZeneca Pharmaceuticals LP ($30.30) |
| 2019 | $59.69 | 4 | PFIZER INC. ($24.51) |
| 2018 | $16.82 | 1 | Janssen Pharmaceuticals, Inc ($16.82) |
| 2017 | $43.95 | 3 | PFIZER INC. ($27.95) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/25/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $31.63 | General |
| Category: Diabetes | ||||||
| 03/23/2023 | SANOFI PASTEUR INC. | FLUZONE QUADRIVALENT NORTHERN HEMISPHERE (Biological), FLUZONE HIGH-DOSE, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Vaccines | ||||||
| 01/24/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: INSOMNIA | ||||||
| 11/03/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Diabetes | ||||||
| 09/23/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Gastroenterology | ||||||
| 07/28/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Diabetes | ||||||
| 07/08/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Gastroenterology | ||||||
| 05/06/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/08/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: Diabetes | ||||||
| 04/06/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Gastroenterology | ||||||
| 02/25/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: RESPIRATORY | ||||||
| 01/25/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Diabetes | ||||||
| 01/21/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: RESPIRATORY | ||||||
| 12/17/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Diabetes | ||||||
| 11/16/2021 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/12/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: NEUROSCIENCE | ||||||
| 10/05/2021 | Althera Pharmaceuticals LLC | Roszet (Drug) | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: Cardiovascular | ||||||
| 10/01/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: RESPIRATORY | ||||||
| 09/03/2021 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Iron Deficiency Anemia | ||||||
| 08/24/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/13/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: RESPIRATORY | ||||||
| 07/09/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/22/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 890 | 1,559 | $164,295 | $90,650 |
| 2022 | 15 | 1,019 | 1,658 | $163,175 | $91,223 |
| 2021 | 13 | 1,040 | 1,729 | $178,375 | $100,314 |
| 2020 | 15 | 973 | 1,780 | $176,632 | $82,692 |
Total Patients
3,922
Total Services
6,726
Medicare Billing
$364,879
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 239 | 755 | $94,375 | $58,281 | 61.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 125 | 125 | $31,250 | $17,394 | 55.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 33 | 35 | $5,950 | $3,830 | 64.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 42 | 42 | $6,300 | $3,173 | 50.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 168 | 300 | $6,000 | $2,520 | 42.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 126 | 133 | $13,300 | $1,663 | 12.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 42 | 42 | $2,100 | $1,511 | 72.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 19 | 23 | $2,185 | $1,180 | 54.0% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 24 | 25 | $1,250 | $794.20 | 63.5% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 39 | 39 | $585.00 | $167.31 | 28.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 33 | 40 | $1,000 | $136.40 | 13.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 229 | 685 | $85,625 | $55,722 | 65.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 126 | 127 | $31,750 | $18,265 | 57.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 35 | $5,950 | $4,051 | 68.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 43 | 43 | $6,450 | $3,021 | 46.8% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 72 | 85 | $4,250 | $2,948 | 69.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 127 | 139 | $13,900 | $1,743 | 12.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 43 | 43 | $2,150 | $1,517 | 70.6% |
| 0013A | Adm sarscov2 100mcg/0.5ml3rd | Office | 2022 | 30 | 32 | $3,200 | $1,498 | 46.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 194 | 339 | $6,780 | $1,001 | 14.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 12 | 13 | $1,235 | $625.92 | 50.7% |
| 0134A | Fee covid-19 vac 14 res | Office | 2022 | 12 | 12 | $600.00 | $555.60 | 92.6% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2022 | 44 | 44 | $660.00 | $190.15 | 28.8% |
| 81002 | Urinalysis, manual test | Office | 2022 | 21 | 25 | $625.00 | $85.85 | 13.7% |
| 91301 | Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage, for intramuscular use | Office | 2022 | 25 | 25 | $0.25 | $0.25 | 100.0% |
About Dr. Richard Boughal, MD
Dr. Richard Boughal, MD is a Internal Medicine healthcare provider based in Northport, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447328059.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Boughal, MD has received a total of $756.92 in payments from pharmaceutical and medical device companies, with $71.86 received in 2023. These payments were reported across 44 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($756.92).
As a Medicare-enrolled provider, Boughal has provided services to 3,922 Medicare beneficiaries, totaling 6,726 services with total Medicare billing of $364,879. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Northport, NY
- Active Since 12/01/2006
- Last Updated 12/26/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1447328059
Products in Payments
- TRELEGY ELLIPTA (Drug) $76.60
- Rybelsus (Drug) $74.43
- INJECTAFER (Drug) $74.42
- XARELTO (Drug) $53.02
- XIFAXAN (Drug) $49.12
- ANORO ELLIPTA (Drug) $48.00
- ENTRESTO (Drug) $34.61
- JARDIANCE (Drug) $31.63
- FARXIGA (Drug) $30.30
- ELIQUIS (Drug) $25.29
- JANUVIA (Drug) $24.73
- CHANTIX (Drug) $24.51
- FLUZONE QUADRIVALENT NORTHERN HEMISPHERE (Biological) $24.28
- UBRELVY (Drug) $22.22
- RYBELSUS (Drug) $20.23
- QULIPTA (Drug) $20.00
- MYRBETRIQ (Drug) $19.21
- VFEND (Drug) $16.50
- Vascepa (Drug) $16.29
- QUVIVIQ (Drug) $15.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Northport
Dr. Stephen Browne, M.d, M.D
Internal Medicine — Payments: $20,215
Internal Medicine $20,215
Brittany Hill, Do, DO
Internal Medicine — Payments: $16,519
Internal Medicine $16,519
Paul Leva, Md, MD
Internal Medicine — Payments: $14,754
Internal Medicine $14,754
Ginny Leva, Md, MD
Internal Medicine — Payments: $8,840
Internal Medicine $8,840
Mr. Roger Perrone, M.d, M.D
Internal Medicine — Payments: $1,748
Internal Medicine $1,748
Dr. Hillary Diamond, M.d, M.D
Internal Medicine — Payments: $601.48
Internal Medicine $601.48